| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |